Vanadium compounds in experimental diabetes: preclinical evidence on hyperglycemia, dyslipidemia, and mechanistic pathways from a scoping review
- DOI
- 10.1016/j.cbi.2026.112309
- Published
- 2026-11
- Container
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.cbi.2026.112309,
title = {Vanadium compounds in experimental diabetes: preclinical evidence on hyperglycemia, dyslipidemia, and mechanistic pathways from a scoping review},
author = {Paula Rothbarth Silva and Nathalia Marçallo Peixoto Souza and Christiane Mayrhofer Grocoske de Lima and Mateus Santana Lopes and Patricia Sthefani Calixto and Luana Mota Ferreira and Geraldo Picheth and Fabiane Gomes de Moraes Rego and Marcel Henrique Marcondes Sari},
year = {2026},
journal = {Chemico-Biological Interactions},
doi = {10.1016/j.cbi.2026.112309},
url = {https://doi.org/10.1016/j.cbi.2026.112309}
}RIS
TY - JOUR TI - Vanadium compounds in experimental diabetes: preclinical evidence on hyperglycemia, dyslipidemia, and mechanistic pathways from a scoping review AU - Paula Rothbarth Silva AU - Nathalia Marçallo Peixoto Souza AU - Christiane Mayrhofer Grocoske de Lima AU - Mateus Santana Lopes AU - Patricia Sthefani Calixto AU - Luana Mota Ferreira AU - Geraldo Picheth AU - Fabiane Gomes de Moraes Rego AU - Marcel Henrique Marcondes Sari PY - 2026 JO - Chemico-Biological Interactions DO - 10.1016/j.cbi.2026.112309 UR - https://doi.org/10.1016/j.cbi.2026.112309 ER -
APA
Silva, P. R., Souza, N. M. P., Lima, C. M. G. D., Lopes, M. S., Calixto, P. S., Ferreira, L. M., Picheth, G., Rego, F. G. D. M., & Sari, M. H. M. (2026). Vanadium compounds in experimental diabetes: preclinical evidence on hyperglycemia, dyslipidemia, and mechanistic pathways from a scoping review. Chemico-Biological Interactions. https://doi.org/10.1016/j.cbi.2026.112309
Source records
- crossref · retrieved 2026-09-25T15:45:45.225Z